Acute Effects of Ginger Extract Consumption on Risk Markers of Cardiovascular Disease
G-CVD
Randomized, Controlled Trial of Ginger Extract Consumption for Healthy Males at Risk of Developing Cardiovascular Disease
1 other identifier
interventional
22
1 country
1
Brief Summary
The primary aim of the study was to investigate the acute effect of ginger drink consumption on the risk markers of cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 8, 2015
CompletedFirst Posted
Study publicly available on registry
April 12, 2016
CompletedApril 12, 2016
April 1, 2016
6 months
December 8, 2015
April 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction in blood pressure (BP)
Reduction in blood pressure (BP)
Six (6) hours
Secondary Outcomes (1)
Flow mediated dilatation
Six (6) hours
Study Arms (2)
Ginger drink
EXPERIMENTALExperimental: Ginger drink (300 ml) to be consumed during the study visit
Placebo: Super pure water
PLACEBO COMPARATORSuper Pure water low in nitrate content
Interventions
Eligibility Criteria
You may qualify if:
- Apparently healthy males,
- Age (30 - 65) years,
- Not diabetic or plasma glucose \> 7 or on anti-diabetic drugs and not on anti- hypertensive drugs.
- Subjects \< 10% risk of cardiovascular disease
You may not qualify if:
- Women,
- Men younger than 30 years and older that 65 years,
- Men who are sick or on anti-diabetic and anti-hypertensive drugs.
- Men who have history of heart attack or stroke within the last 12 months
- Men who are on lipids lowering drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Food and Nutritional Sciences
Reading, Berkshire, RG6 6AP, United Kingdom
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Jeremy PE Spencer, Professor
University of Reading
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 8, 2015
First Posted
April 12, 2016
Study Start
February 1, 2014
Primary Completion
August 1, 2014
Study Completion
August 1, 2014
Last Updated
April 12, 2016
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will not share